<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JOCR</journal-id><journal-title-group><journal-title>Journal of Organic Chemistry Research</journal-title></journal-title-group><issn pub-type="epub">2330-5231</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/JOCR.2016.41002</article-id><article-id pub-id-type="publisher-id">JOCR-17107</article-id><article-categories><subj-group subj-group-type="heading"><subject>JOCR20160100000_67816085.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>化学与材料</subject></subj-group></article-categories><title-group><article-title>
 
 
  银促进的α-氨基芳乙酮与NH
  <sub>4</sub>PF
  <sub>6</sub>的缩合环化反应：2-芳甲酰基咪唑衍生物的合成研究
  Silver-Promoted Cyclization of α-Aminoacetophenone with NH
  <sub>4</sub>PF
  <sub>6</sub>: Synthesis of 2-Arylformylimidazole Derivatives
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>祚辉</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>程</surname><given-names>晓雪</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>浩</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>凌</surname><given-names>心茹</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>赵</surname><given-names>晨晨</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>胡</surname><given-names>茂林</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff2"><addr-line>温州大学化学与材料工程学院，浙江 温州</addr-line></aff><pub-date pub-type="epub"><day>07</day><month>03</month><year>2016</year></pub-date><volume>04</volume><issue>01</issue><fpage>6</fpage><lpage>12</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   本文发展了一种由六氟磷酸铵提供铵源，与两分子α-氨基芳乙酮在醋酸银的氧化作用下，经过缩合、脱胺、环化等串联反应合成2-芳甲酰基咪唑衍生物的新方法。在最优条件下，合成了8种2-芳甲酰基咪唑衍生物，收率为52%~93%。所有的产物结构通过IR、NMR和MS等手段表征。该方法具有原料简单易得、操作简便等优点。 A new method for AgOAc-oxidative cyclization of α-aminoacetophenones with NH4PF6 leading to 2-arylformylimidazoles derivatives has been developed. Under the optimal reaction conditions, a wide range of 2-arylformylimidazoles derivatives were synthesized in moderate to good yields ranging from 52% to 93%. These products were confirmed by IR, NMR and MS. The results show that this method has advantages such as the availability for raw materials and simple chemical operations.
    
  
 
</p></abstract><kwd-group><kwd>α-氨基芳乙酮，咪唑，缩合反应，环化反应，氧化脱胺, α-Aminoacetophenone</kwd><kwd> Imidazole</kwd><kwd> Condensation</kwd><kwd> Cyclization</kwd><kwd> Oxidative Deamination</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>银促进的α-氨基芳乙酮与NH<sub>4</sub>PF<sub>6</sub>的缩合环化反应：2-芳甲酰基咪唑衍生物的合成研究<sup> </sup></title><p>王祚辉，程晓雪，王浩，凌心茹，赵晨晨，胡茂林<sup>*</sup></p><p>温州大学化学与材料工程学院，浙江 温州</p><disp-formula id="hanspub.17107-formula229"><graphic xlink:href="http://html.hanspub.org/file/2-2970046x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2016年2月15日；录用日期：2016年3月7日；发布日期：2016年3月10日</p><disp-formula id="hanspub.17107-formula230"><graphic xlink:href="http://html.hanspub.org/file/2-2970046x8_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>本文发展了一种由六氟磷酸铵提供铵源，与两分子α-氨基芳乙酮在醋酸银的氧化作用下，经过缩合、脱胺、环化等串联反应合成2-芳甲酰基咪唑衍生物的新方法。在最优条件下，合成了8种2-芳甲酰基咪唑衍生物，收率为52%~93%。所有的产物结构通过IR、NMR和MS等手段表征。该方法具有原料简单易得、操作简便等优点。</p><p>关键词 :α-氨基芳乙酮，咪唑，缩合反应，环化反应，氧化脱胺</p><disp-formula id="hanspub.17107-formula231"><graphic xlink:href="http://html.hanspub.org/file/2-2970046x9_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s3"><title>1. 引言</title><p>咪唑作为一种重要的氮杂五元骨架，不仅是生物体内肌肽、组氨酸、组胺、嘌呤等重要生命物质的基本单元，而且存在于多种农药、医药化合物中，如杀虫剂、除草剂、灭菌剂等[<xref ref-type="bibr" rid="hanspub.17107-ref1">1</xref>] ，以及降压药氯沙坦[<xref ref-type="bibr" rid="hanspub.17107-ref2">2</xref>] 、抗消化性溃疡药甲氰咪胺[<xref ref-type="bibr" rid="hanspub.17107-ref3">3</xref>] 、抗肿瘤药物4H-吡咯并[1,2-a]苯并咪唑(PBIS)衍生物[<xref ref-type="bibr" rid="hanspub.17107-ref4">4</xref>] -[<xref ref-type="bibr" rid="hanspub.17107-ref6">6</xref>] 等。此外，咪唑化合物还具有良好的配位性能，不仅易与金属离子配位形成金属配合物 [<xref ref-type="bibr" rid="hanspub.17107-ref7">7</xref>] ，还可作为多种酶的活性中心功能基[<xref ref-type="bibr" rid="hanspub.17107-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.17107-ref8">8</xref>] 。由于咪唑化合物具有众多优良的性能，被广泛应用于生物、工业和有机合成领域中。因此，百余年来咪唑及其衍生物的合成及应用研究从未间断，至今仍十分活跃[<xref ref-type="bibr" rid="hanspub.17107-ref9">9</xref>] 。咪唑环的合成方法众多，据文献报道主要有如下一些方法：乙二醛(1，2-二酮)-醛-氨法[<xref ref-type="bibr" rid="hanspub.17107-ref10">10</xref>] -[<xref ref-type="bibr" rid="hanspub.17107-ref12">12</xref>] 、α-氨基缩醛法[<xref ref-type="bibr" rid="hanspub.17107-ref13">13</xref>] 、直接缩聚法[<xref ref-type="bibr" rid="hanspub.17107-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.17107-ref15">15</xref>] 、异腈法[<xref ref-type="bibr" rid="hanspub.17107-ref16">16</xref>] 、α-氨基氰法[<xref ref-type="bibr" rid="hanspub.17107-ref17">17</xref>] 、α-酰氨基希夫碱法[<xref ref-type="bibr" rid="hanspub.17107-ref18">18</xref>] 、Claisen重排反应法[<xref ref-type="bibr" rid="hanspub.17107-ref19">19</xref>] 、钯催化环化合成法[<xref ref-type="bibr" rid="hanspub.17107-ref20">20</xref>] 等。2-芳甲酰基咪唑衍生物最初从海鞘类动物体内分离出，近年来，该类化合物在生物学研究领域中备受关注[<xref ref-type="bibr" rid="hanspub.17107-ref21">21</xref>] [<xref ref-type="bibr" rid="hanspub.17107-ref22">22</xref>] 。但有关2-苯甲酰基-5-苯基咪唑及其衍生物的合成鲜有报道。已报道的该类化合物的合成方法主要有以下两种：1) 以芳基乙二醛为原料制备2-苯甲酰基-5-苯基咪唑[<xref ref-type="bibr" rid="hanspub.17107-ref23">23</xref>] [<xref ref-type="bibr" rid="hanspub.17107-ref24">24</xref>] 。但是该方法中使用的原料芳基乙二醛不易获取，需要复杂的制备过程；2) 以α-叠氮基芳乙酮为原料制备2-苯甲酰基-5-苯基咪唑[<xref ref-type="bibr" rid="hanspub.17107-ref25">25</xref>] [<xref ref-type="bibr" rid="hanspub.17107-ref26">26</xref>] 。但是叠氮化合物有毒、易爆炸，而且反应后处理复杂，限制了其应用范围。</p><p>本文以α-氨基芳乙酮和六氟磷酸铵为原料，通过反应条件的优化，建立了一种合成2-芳甲酰基咪唑衍生物的反应新方法。在醋酸银的作用下，α-氨基芳乙酮发生碳氮键断裂，与铵离子缩合环化，最终生成2-芳甲酰基咪唑衍生物。本文合成2-芳甲酰基咪唑衍生物的技术方法具有原料简单易得、反应后处理简单等特点。采用红外光谱(IR)、核磁共振波谱(<sup>1</sup>H NMR, <sup>13</sup>C NMR)和质谱(MS)对产物进行了结构表征。</p></sec><sec id="s4"><title>2. 实验部分</title><sec id="s4_1"><title>2.1. 试剂与仪器</title><p>WRS-1B型数字熔点仪(上海申光仪器仪表有限公司)；Bruker EQUINOX55型红外分光光度计(瑞士布鲁克公司)；Avance-III AV500 核磁共振仪(瑞士布鲁克公司，TMS为内标，DMSO-d<sub>6</sub>为溶剂)；GC(7890A)-MS(5975C)型气相色谱–质谱联用仪(美国安捷伦公司)；Bruker micrOTOF-Q II高分辨率质谱仪(美国布鲁克–道尔顿公司)；薄层层析硅胶用GF254硅胶和HF254型柱层析硅胶(烟台江友硅胶开发有限公司)。石油醚和乙酸乙酯经过重蒸纯化，其它试剂均为进口或国产市售分析纯。原料α-氨基芳乙酮根据文献[<xref ref-type="bibr" rid="hanspub.17107-ref27">27</xref>] 的方法合成。</p></sec><sec id="s4_2"><title>2.2. 化合物4a~4i(5a~5i) (4,5互为同分异构体)的合成及产物表征：</title><p>化合物4a~4i (5a~5i)的合成反应如图1所示。向15 mL反应管(SYNTHWARE)中依次加入磁力搅拌子、α-(N-甲基-N-苯基)-苯乙酮(3)(0.20 mmol)、AgOAc (66.8 mg，0.40 mmol，2.0 equiv)、NH<sub>4</sub>PF<sub>6</sub> (65.2 mg，0.40 mmol，2.0 equiv)、HFIP(六氟异丙醇)与CH<sub>3</sub>CN (v:v = 1:5) 的混合溶液(2 mL)，于130℃下搅拌回流反应。用薄层色谱(TLC)监测反应进程，反应完成后冷却至室温，用25 mL乙酸乙酯稀释，过滤分离出固体物质，减压蒸除溶剂，粗产物经柱层析[v(石油醚)/v(乙酸乙酯) = 10:1~5:1]分离得到化合物4与5。化合物4与5互为同分异构体，我们尝试分离这两种化合物，然而由于4与5之间相互快速转化[<xref ref-type="bibr" rid="hanspub.17107-ref24">24</xref>] ，因此未能分离出它们。目标化合物的表征结果见表1和表2。</p><p>图1. 化合物4a~4h与5a~5h的合成</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Feature, yields, MS, HRMS and IR data for compounds 4a-4h and 5a-5</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Compd.</th><th align="center" valign="middle" >Feature</th><th align="center" valign="middle" >m.p./˚C</th><th align="center" valign="middle" >Yield<sup>*</sup>(%)</th><th align="center" valign="middle" >LRMS (EI, 70 eV), m/z (%)</th><th align="center" valign="middle" >HRMS (ESI) [M+H]<sup>+</sup>(calcd.), m/z</th><th align="center" valign="middle" >IR (KBr) ν/cm<sup>−1</sup></th></tr></thead><tr><td align="center" valign="middle" >4a,5a</td><td align="center" valign="middle" >Yellow solid</td><td align="center" valign="middle" >278.6</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >249 (18), 247 (10), 220 (100), 105(53)</td><td align="center" valign="middle" >249.1033 (249.1023)</td><td align="center" valign="middle" >3257, 1625, 1464, 1298, 1288, 1171, 909, 759, 686</td></tr><tr><td align="center" valign="middle" >4a,5a</td><td align="center" valign="middle" >Yellow solid</td><td align="center" valign="middle" >278.6</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >249 (18), 247 (10), 220 (100), 105 (53)</td><td align="center" valign="middle" >249.1033 (249.1023)</td><td align="center" valign="middle" >3257, 1625, 1464, 1298, 1288, 1171, 909, 759, 686</td></tr><tr><td align="center" valign="middle" >4b,5b</td><td align="center" valign="middle" >Yellow solid</td><td align="center" valign="middle" >184.6</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >276 (96), 248 (100), 130 (10), 119 (75)</td><td align="center" valign="middle" >277.1341 (277.1335)</td><td align="center" valign="middle" >3274, 1618, 1455, 1374, 1291, 1271, 1169, 906, 769, 702</td></tr><tr><td align="center" valign="middle" >4c,5c</td><td align="center" valign="middle" >Yellow solid</td><td align="center" valign="middle" >187.4</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >309 (17), 308 (78), 265 (28), 135 (100)</td><td align="center" valign="middle" >309.1243 (309.1234)</td><td align="center" valign="middle" >3263, 1611, 1599, 1450, 1288, 1247, 1160, 1029, 905, 831, 775, 657</td></tr><tr><td align="center" valign="middle" >4d,5d</td><td align="center" valign="middle" >Yellow solid</td><td align="center" valign="middle" >113.0</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >285 (17), 284 (100), 135 (74), 95 (51)</td><td align="center" valign="middle" >285.0831 (285.0834)</td><td align="center" valign="middle" >3248, 1627, 1469, 1385, 1310, 1289, 1264, 1245, 1170, 1040, 940, 868, 761, 680</td></tr><tr><td align="center" valign="middle" >4e,5e</td><td align="center" valign="middle" >Yellow solid</td><td align="center" valign="middle" >171.0</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >318 (50), 316 (77), 207 (53), 139 (100)</td><td align="center" valign="middle" >317.0257 (317.0243)</td><td align="center" valign="middle" >3269, 2921, 2847, 1614, 1584, 1469, 1451, 1292, 1168, 1100, 1015, 904, 835, 771</td></tr><tr><td align="center" valign="middle" >4f,5f</td><td align="center" valign="middle" >Brown solid</td><td align="center" valign="middle" >257.9</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >408 (48), 406 (100), 380 (39), 157 (67)</td><td align="center" valign="middle" >404.9243 (404.9233)</td><td align="center" valign="middle" >3257, 2914, 1679, 1580, 1451, 1320, 1169, 1071, 1022, 1012, 903, 832, 770, 713, 665</td></tr><tr><td align="center" valign="middle" >4g,5g</td><td align="center" valign="middle" >Brown solid</td><td align="center" valign="middle" >272.3</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >298 (66), 270 (100), 130 (72), 102 (84)</td><td align="center" valign="middle" >299.0944 (299.0928)</td><td align="center" valign="middle" >3280, 2217, 1635, 1607, 1464, 1320, 1301, 1177, 1146, 914, 768, 681</td></tr><tr><td align="center" valign="middle" >4h,5h</td><td align="center" valign="middle" >Yellow solid</td><td align="center" valign="middle" >200.6</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >385 (16), 384 (78), 356 (100), 173 (42)</td><td align="center" valign="middle" >385.0769 (385.0770)</td><td align="center" valign="middle" >3274, 1632, 1615, 1478, 1328, 1292, 1169, 1112, 1065, 1014, 910, 785, 682</td></tr></tbody></table></table-wrap><p>表1. 化合物4a~4h与5a~5h的特征、产率、低分辨质谱、高分辨质谱及红外光谱表征</p><p><sup>*</sup>Yield after purification by column chromatography on silica gel.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> 1H NMR, 13C NMR data of compounds 4a—4h (5a—5h</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Compd.</th><th align="center" valign="middle" ><sup>1</sup>H NMR (500 MHz, DMSO-d<sub>6</sub>), δ</th><th align="center" valign="middle" ><sup>13</sup>C NMR (500 MHz, DMSO-d<sub>6</sub>), δ</th></tr></thead><tr><td align="center" valign="middle" >4a, 5a</td><td align="center" valign="middle"  rowspan="2"  >13.84 (0.19H, s, NH), 13.68 (1H, s, NH), 8.64 (d, J = 7.0 Hz, 2H), 8.50 (d, J = 7.0 Hz, 0.41H), 8.09 (s, 1H), 7.97 (d, J = 6.0 Hz, 2H), 7.80 (s, 0.24H), 7.69～7.64 (m, 1H), 7.62~7.54 (m, 2H), 7.47～7.41 (m, 2H), 7.35 (t, J = 7.0 Hz, 0.25H), 7.28 (t, J = 7.0 Hz, 1H)</td><td align="center" valign="middle"  rowspan="2"  >181.0, 180.8, 145.8, 144.7, 142.9, 136.2, 136.0, 135.7, 133.7, 133.0, 132.9, 132.8, 130.7, 130.5, 128.9, 128.6, 128.5, 128.3, 128.2, 128.1, 127.1, 127.0, 125.7, 124.9, 118.6, 118.5</td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4b, 5b</td><td align="center" valign="middle"  rowspan="2"  >13.67 (0.32H, s, NH), 13.53 (1H, s, NH), 8.54 (d, J = 8.0 Hz, 2H), 8.43 (d, J = 8.0 Hz, 0.68H), 7.99 (d, J = 2.0 Hz, 1H), 7.85 (d, J = 8.0 Hz, 0.66H), 7.83 (d, J = 8.0 Hz, 2H), 7.72 (d, J = 2.0 Hz, 0.34H), 7.40 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 8.0 Hz, 0.75H), 7.26(d, J = 8.0 Hz, 0.68H), 7.23 (d, J = 8.0 Hz, 2H), 2.42 (s, 3H), 2.40 (s, 1H), 2.33(s, 1H), 2.32 (s, 3H)</td><td align="center" valign="middle"  rowspan="2"  >180.4, 180.3, 145.7, 144.7, 143.4, 143.2, 142.9, 137.7, 136.2, 135.7, 133.6, 133.4, 131.0, 130.8, 130.7, 129.4, 129.2, 128.9, 128.7, 128.3, 125.9, 125.6, 124.8, 117.8, 21.2, 20.8</td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4c, 5c</td><td align="center" valign="middle"  rowspan="2"  >13.56 (0.26H, s, NH), 13.45 (1H, s, NH), 8.71 (d, J = 8.5 Hz, 2H), 8.57 (d, J = 8.5 Hz, 0.60H), 7.92 (d, J = 1.5 Hz, 1H), 7.89 (s, 0.28H), 7.87 (d, J = 8.5 Hz, 2H), 7.65 (s, 0.26H), 7.13 (d, J = 8.5 Hz, 2H), 7.09 (d, J = 8.5 Hz, 0.70H), 7.02 (s, 0.28H), 6.99 (d, J = 8.5 Hz, 2H), 3.88 (s, 2H), 3.86 (s, 1H), 3.80 (s, 1H), 3.78 (s, 2H)</td><td align="center" valign="middle"  rowspan="2"  >179.1, 178.9, 163.2, 163.0, 159.3, 158.6, 145.6, 144.7, 142.7, 135.4, 133.1, 132.9, 128.9, 128.7, 127.6, 127.1, 126.5, 126.1, 121.3, 116.9, 114.3, 114.0, 113.6, 113.5, 55.5, 55.2, 55.1</td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4d, 5d</td><td align="center" valign="middle"  rowspan="2"  >13.79(0.17H, s, NH), 12.63 (1H, s, NH), 8.71 ( t, J = 6.5Hz, 2H), 8.58( t, J = 6.5 Hz, 0.38H), 8.05 (s, 1H), 8.00 (dd, J = 8.0 Hz, 0.42H), 7.95 ( dd, J = 8.0Hz, 2H), 7.74 (s, 0.18H), 7.40 (t, J = 8.8 Hz, 2H), 7.36 (d, J = 8.0 Hz, 0.35H), 7.29 (d, J = 9.0 Hz, 0.39H), 7.24 (t, J = 8.8 Hz, 2H)</td><td align="center" valign="middle"  rowspan="2"  >179.0, 166.1, 164.1, 162.5, 160.5, 145.6, 144.5, 142.0, 134.9, 133.6 (d, J = 9.3 Hz), 133.5 (d, J = 9.3 Hz), 132.5 (d, J = 2.8 Hz), 130.1 (d, J = 2.8 Hz), 128.8, 127.9 (d, J = 8.0 Hz), 126.8 (d, J = 8.0 Hz), 118.4, 115.8 (d, J = 21.5 Hz), 115.5-115.2 (m), 115.1</td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4e, 5e</td><td align="center" valign="middle"  rowspan="2"  >13.87 (0.15H, s, NH), 13.71 (1H, s, NH), 8.59 (d, J = 7.8 Hz, 2H), 8.50 (s, 0.29H), 8.11 (s, 1H), 7.94 (d, J = 7.9 Hz, 2H), 7.82 (s, 0.27H), 7.67 (d, J = 8.1 Hz, 2H), 7.48 (d, J = 7.9 Hz, 2H)</td><td align="center" valign="middle"  rowspan="2"  >179.4, 170.3, 144.5, 141.8, 138.2, 137.7, 134.5, 132.6, 132.5, 131.6, 131.5, 131.4, 131.1, 129.6, 128.7, 128.6, 128.5, 127.4, 126.9, 126.5, 119.3</td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4f, 5f</td><td align="center" valign="middle"  rowspan="2"  >13.91 (0.14H, s, NH), 13.74 (1H, s, NH), 8.51 (d, J = 8.4 Hz, 2H), 8.42 (d, J = 8.4 Hz, 0.30H), 8.16 (s, 1H), 7.93 (d, J = 8.4 Hz, 0.33H), 7.89 (d, J = 8.4 Hz, 2H), 7.82 (d, J = 8.4 Hz, 2H), 7.79 (d, J = 8.4 Hz, 0.43H), 7.66 (d, J = 8.4Hz, 0.32H), 7.61 (d, J = 8.4 Hz, 2H)</td><td align="center" valign="middle"  rowspan="2"  >179.7, 174.3, 144.5, 141.8, 134.8, 132.8, 132.6, 132.5, 131.9, 131.5, 131.4, 131.3, 129.6, 129.4, 127.7, 127.4, 126.9, 120.1, 119.3</td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4g, 5g</td><td align="center" valign="middle"  rowspan="2"  >14.16 (0.07H, s, NH), 13.97 (1H, s, NH), 8.66 (d, J = 8.5 Hz, 2H), 8.55 (d, J = 8.0 Hz, 0.15H), 8.36 (d, J = 2.0 Hz, 1H), 8.17 (d, J = 8.0 Hz, 0.17H), 8.15 (d, J = 4.0 Hz, 0.10H), 8.11 (d, J = 8.5 Hz, 2H), 8.08 (d, J = 8.5 Hz, 2H), 7.93 (d, J = 8.5 Hz, 0.24H), 7.90 (d, J = 8.5 Hz, 2H)</td><td align="center" valign="middle"  rowspan="2"  >184.9, 175.5, 149.9, 146.6, 144.5, 143.1, 137.9, 137.5, 136.4, 136.3, 130.7, 126.7, 126.6, 124.2, 123.5, 120.3, 114.6</td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4h, 5h</td><td align="center" valign="middle"  rowspan="2"  >14.14 (0.10H, s, NH), 13.91 (1H, s, NH), 8.69 (d, J = 8.0 Hz, 2H), 8.60 (d, J = 8.0 Hz, 0.21H), 8.30 (s, 1H), 8.19 (d, J = 8.0 Hz, 0.21H), 8.13 (d, J = 8.0 Hz, 2H), 7.96 (d, J = 8.0 Hz, 2H), 7.87 (d, J = 8.0 Hz, 0.10 H), 7.84 (s, 0.06H), 7.81 (d, J = 8.0 Hz, 0.23H), 7.76 (d, J = 8.0 Hz, 2H)</td><td align="center" valign="middle"  rowspan="2"  >180.0, 144.6, 141.6, 139.2, 137.4, 132.5, 132.2, 131.3, 127.5, 127.2, 125.5(d, J = 1.5 Hz), 125.3, 125.2 (d, J = 1.5 Hz), 124.9, 123.3, 122.8, 120.7</td></tr><tr><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>表2. 化合物4a—4h (5a—5h)的<sup>1</sup>H NMR，<sup>13</sup>C NMR结构表征</p></sec></sec><sec id="s5"><title>3. 结果与讨论</title><sec id="s5_1"><title>3.1. 反应条件的优化</title><p>以α-(N-甲基-N-苯基)-苯乙酮(3a, 0.20 mmol)合成2-苯甲酰基-4(或5)-苯基咪唑(4a, 5a)的反应作为合成2-芳甲酰基咪唑衍生物的反应的模型，分别对氧化剂、铵源、反应温度和反应溶剂等条件进行优化，结果见表3。</p><p>首先将原料α-(N-甲基-N-苯基)-苯乙酮3a、醋酸银、六氟磷酸铵、六氟异丙醇与乙腈(v:v = 1:5)的混合溶剂加入反应管，于130℃反应12 h，发现生成痕量的产物4a与5a (表3，Entry 1)。对反应溶剂进行筛选，结果表明，选用体积比为1:5的六氟异丙醇(HFIP)与乙腈(CH<sub>3</sub>CN)的混合溶剂，收率达到93% (Entries 1~7)。选用醋酸铵(NH<sub>4</sub>OAc)作为铵源，反应的收率明显下降(Entry 8)。当反应温度为110℃时，反应收率为84% (Entry 9)。继续降低反应温度至90℃，或者缩短反应时间，原料α-(N-甲基-N-苯基)-苯乙酮没有反应完，导致收率降低(Entries 10 and 11)。在确定了合适的溶剂和反应温度等条件后，对氧化剂进行了考察，对比分别加入氧化银(Ag<sub>2</sub>O)、碳酸银(Ag<sub>2</sub>CO<sub>3</sub>)、硝酸银(AgNO<sub>3</sub>)，以及双氧水、过硫酸钾(K<sub>2</sub>S<sub>2</sub>O<sub>8</sub>)等氧化剂，均能促进反应的进行，但都不如醋酸银的反应效果明显(Entries 12~18)。增加或减少醋酸银的量，均不能继续提高收率(Entry 19, 20)。通过对实验条件的筛选和优化，最终确定了130℃下以两当量的醋酸银作氧化剂，两当量的六氟磷酸铵为铵源，体积比为1:5的六氟异丙醇与乙腈的混合溶剂作为反应溶剂</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Optimization of reaction conditions</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Entry</th><th align="center" valign="middle" >Oxidant(eq)</th><th align="center" valign="middle" >[NH4<sup>+</sup>]</th><th align="center" valign="middle" >Solvent (volumeratio)</th><th align="center" valign="middle" >Temperature /℃</th><th align="center" valign="middle" >Time /h</th><th align="center" valign="middle" >Yield<sup>b</sup>(%)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >Trace</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >DCE</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >CH<sub>3</sub>CN</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >21</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:1)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >70</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >93</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/t-BuOH ( 1:5 )</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >21</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >PrCN/CH<sub>3</sub>CN ( 1:5 )</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >24</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>OAc</td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >51</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >110</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >84</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >76</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >AgOAc (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >81</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >Ag<sub>2</sub>O (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >48</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >Ag<sub>2</sub>CO<sub>3</sub> (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >Trace</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >AgNO<sub>3</sub>(2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >12</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >H<sub>2</sub>O<sub>2</sub>(2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >59</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >K<sub>2</sub>S<sub>2</sub>O<sub>8</sub>(2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >53</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >V(oacac)<sub>5</sub> (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >17</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >Mn(OAc)<sub>2</sub>∙2H<sub>2</sub>O (2)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >50</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >AgOAc (1.5)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >53</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >AgOAc (3)</td><td align="center" valign="middle" >NH<sub>4</sub>PF<sub>6</sub></td><td align="center" valign="middle" >HFIP/CH<sub>3</sub>CN (1:5)</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >69</td></tr></tbody></table></table-wrap><p>表3. 反应条件的优化<sup>a</sup></p><disp-formula id="hanspub.17107-formula232"><graphic xlink:href="http://html.hanspub.org/file/2-2970046x11_hanspub.png"  xlink:type="simple"/></disp-formula><p><sup>a</sup>Reaction conditions: 0.2 mmol compound 3a, oxidantand 0.2 mmol [NH4<sup>+</sup>] (2 eq) in 2 mL solvent; <sup>b</sup>isolated yield aftercolumn chromatographic purification.</p><p>的最优反应条件。在此条件下，α-(N-甲基-N-苯基)-苯乙酮(3a)合成2-苯甲酰基-4-苯基咪唑(4a)与2-苯甲酰基-5-苯基咪唑(5a)的反应可以获得最高的收率。</p></sec><sec id="s5_2"><title>3.2. 反应底物的扩展</title><p>对反应底物的拓展研究结果(表4)表明，苯环上对位存在供电子基团的2-芳甲酰基咪唑衍生物的反应收率相对较高(表4，Entries 2~4，收率为73%~83%)。苯环上对位存在吸电子基团的2-芳甲酰基咪唑衍生物，其反应收率相对较低(表4，Entries 6~9，收率为52%~69%)。当苯环上不含取代基时，反应的收率最高(表4，Entry 1，收率为93%)。实验结果表明，α-(N-甲基-N-苯基)-苯乙酮合成2-芳甲酰基咪唑衍生物的反应活性与苯环上取代基的类型、位置密切相关，苯环上对位取代基的给电子作用越强，α-(N-甲基-N-苯基)-芳乙酮合成2-芳甲酰基咪唑衍生物的反应活性越高。我们合成的产物核磁共振谱图出现两组峰，<sup>1</sup>H NMR谱图显</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Substrate scope</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Entry</th><th align="center" valign="middle" >Compd.</th><th align="center" valign="middle" >Yield<sup>b</sup>(%)</th><th align="center" valign="middle" >4/5 Ratio</th><th align="center" valign="middle" >Entry</th><th align="center" valign="middle" >Compd.</th><th align="center" valign="middle" >Yield<sup>b</sup>(%)</th><th align="center" valign="middle" >4/5 Ratio</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/2-2970046x12_hanspub.png" xlink:type="simple"/></inline-formula> (4a,5a)</td><td align="center" valign="middle" >93%</td><td align="center" valign="middle" >4.0</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/2-2970046x13_hanspub.png" xlink:type="simple"/></inline-formula> (4e,5e)</td><td align="center" valign="middle" >58%</td><td align="center" valign="middle" >5.7</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/2-2970046x14_hanspub.png" xlink:type="simple"/></inline-formula> (4b,5b)</td><td align="center" valign="middle" >73%</td><td align="center" valign="middle" >3.4</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/2-2970046x15_hanspub.png" xlink:type="simple"/></inline-formula> (4f,5f)</td><td align="center" valign="middle" >69%</td><td align="center" valign="middle" >5.3</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/2-2970046x16_hanspub.png" xlink:type="simple"/></inline-formula> (4c,5c)</td><td align="center" valign="middle" >80%</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/2-2970046x17_hanspub.png" xlink:type="simple"/></inline-formula> (4g,5g)</td><td align="center" valign="middle" >65%</td><td align="center" valign="middle" >11.1</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/2-2970046x18_hanspub.png" xlink:type="simple"/></inline-formula> (4d,5d)</td><td align="center" valign="middle" >83%</td><td align="center" valign="middle" >5.2</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/2-2970046x19_hanspub.png" xlink:type="simple"/></inline-formula> (4h,5h)</td><td align="center" valign="middle" >52%</td><td align="center" valign="middle" >9.8</td></tr></tbody></table></table-wrap><p>表4. 底物拓展<sup>a</sup></p><p><sup>a</sup>Reaction conditions: 0.2 mmol compound 3, 0.4 mmol AgOAc (2 eq), 0.4 mmol NH<sub>4</sub>PF<sub>6</sub> (2 eq) in 2 mL HFIP/CH<sub>3</sub>CN (v:v= 1:5) at 130℃ for 12 h;</p><p><sup>b</sup>isolated yield after column chromatographic purification.</p><p>示化合物4比5的NH化学位移值小，根据两种同分异构体在<sup>1</sup>H NMR谱图中的NH峰面积，我们计算出4、5两种化合物的比例(a/b Ratio)，结果如表4所示。</p></sec></sec><sec id="s6"><title>4. 结论</title><p>我们研究了以α-氨基芳乙酮为原料，通过碳氮键的断裂，串联环化合成2-芳甲酰基咪唑衍生物的反应。通过条件筛选,确定了130℃下,以两当量的醋酸银作催化剂,两当量的六氟磷酸铵为铵源，六氟异丙醇与乙腈(体积比：1:5)的混合溶剂作为反应溶剂的最佳反应条件。在此反应条件下，α-(N-甲基-N-苯基)-苯乙酮合成2-苯甲酰基-4(或5)-苯基咪唑(4a, 5a)的反应产率可达93%。该反应具有操作简便、原料简单易得等特点，通过α-氨基芳乙酮与六氟磷酸铵的串联环化反应，提供了一条有效制备2-芳甲酰基咪唑衍生物的反应新方法。</p></sec><sec id="s7"><title>文章引用</title><p>王祚辉,程晓雪,王 浩,凌心茹,赵晨晨,胡茂林. 银促进的α-氨基芳乙酮与NH<sub>4</sub>PF<sub>6</sub>的缩合环化反应：2-芳甲酰基咪唑衍生物的合成研究Silver-Promoted Cyclization of α-Aminoacetophenone with NH<sub>4</sub>PF<sub>6</sub>: Synthesis of 2-Arylformylimidazole Derivatives[J]. 有机化学研究, 2016, 04(01): 6-12. http://dx.doi.org/10.12677/JOCR.2016.41002</p></sec><sec id="s8"><title>参考文献 (References)</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.17107-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">伍晓春. 咪唑类化合物的合成与应用研究[J]. 精细与专用化学品, 2010, 18(7): 51-55.</mixed-citation></ref><ref id="hanspub.17107-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">刘凤珍, 吴炎, 赵智斌, 谢淑英, 张锐, 高嵩. 氯沙坦降压疗效及对血管活性物质的影响[J]. 高血压杂志, 2000, 8(1): 43-44.</mixed-citation></ref><ref id="hanspub.17107-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Brogden, R.N., Heel, R.C., Speight, T.M. and Avery, G.S. (1978) Cimetidine: A Review of Its Pharmacological Properities and Therapeutic Efficacy in Peptic Ulcer Disease. Drugs, 15, 93-131.  
&lt;br&gt;http://dx.doi.org/10.2165/00003495-197815020-00002</mixed-citation></ref><ref id="hanspub.17107-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Zhou, R. and Skibo, E.B. (1996) Chemistry of the Pyrrolo[1,2-a]benzimidazole Antitumor Agents: Influence of the 7- su-bstituent on the Ability to Alkylate DNA and Inhibit Topoisomerase II. Journal of Medicinal Chemistry, 39, 4321- 4331. &lt;br&gt;http://dx.doi.org/10.1021/jm960064d</mixed-citation></ref><ref id="hanspub.17107-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Skibo, E.B., Gordon, S., Bess, L., Boruah, R. and Heileman, M.J. (1997) Studies of Pyrrolo[1,2-a]benzimidazolequi- None DT-Diaphorase Substrate Activity, Topoisomerase II Inhibition Activity, and DNA Reductive Alkylation. Journal of Medicinal Chemistry, 40, 1327-1339. &lt;br&gt;http://dx.doi.org/10.1021/jm960546p</mixed-citation></ref><ref id="hanspub.17107-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Craigo, W.A., Le Sueur, B.W. and Skibo, E.B. (1999) Design of Highly Active Analogues of Thepyrrolo[1,2-a]ben- zimidazole Antitumor Agents. Journal of Medicinal Chemistry, 42, 3324-3333. &lt;br&gt;http://dx.doi.org/10.1021/jm990029h</mixed-citation></ref><ref id="hanspub.17107-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kirchner, C. and Krebs, B. (1987) Pentacoordinate Zinc Complexes of Imidazole Nitrogen Donors as Structural Models for the Active Site in Enzymes: Preparation and Crystal Structures of (μ-2,2'-Biimidazolet)tetrakis(2,2'-biimidazole) dizinc(II) Tetraperchlorate Trihydrate and Bis(2,2'-biimidazole)(formato)zinc(II) perchlorate. Inorganic Chemistry, 26, 3569-3576. &lt;br&gt;http://dx.doi.org/10.1021/ic00268a030</mixed-citation></ref><ref id="hanspub.17107-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">李云中, 侯自杰. 具有生物活性的咪唑类化合物的合成研究[J]. 有机化学, 2003(23): 426.</mixed-citation></ref><ref id="hanspub.17107-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">马文展, 刘少文, 胡建. 咪唑及其衍生物的合成[J]. 化学试剂, 1997, 19(5): 281-285.</mixed-citation></ref><ref id="hanspub.17107-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Gridnev, A.A. and Mihaltseva, I.M. (1994) Synthesis of 1-Alkylimidazoles. Synthetic Communications, 24, 1547-1555.  
&lt;br&gt;http://dx.doi.org/10.1080/00397919408010155</mixed-citation></ref><ref id="hanspub.17107-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, S.D., Hazarika, P. and Konwar, D. (2008) An Effi-cient and One-Pot Synthesis of 2,4,5-trisubstituted and 1,2,4,5-tetrasubstituted Imidazoles Catalyzed by InCl3•3H2O. Tetrahedron Letters, 49, 2216-2220.  
&lt;br&gt;http://dx.doi.org/10.1016/j.tetlet.2008.02.053</mixed-citation></ref><ref id="hanspub.17107-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Maleki, B. and Ashrafi, S.S. (2014) N-Bromosuccinimide Catalyzed Three Component One-Pot Efficient Synthesis of 2,4,5-triaryl-1H-imidazoles from Aldehyde, Ammonium Acetate, and 1,2-diketone or α-Hydroxyketone. Journal of the Mexican Chemical Society, 58, 76-81.</mixed-citation></ref><ref id="hanspub.17107-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Mulliez, E. (1989) Synthesis of Polyimidazolesas Biomimetic Ligands Formetalloprotein Activesite Modeling. Tetrahedron Letters, 30, 6169-6172. &lt;br&gt;http://dx.doi.org/10.1016/S0040-4039(01)93333-7</mixed-citation></ref><ref id="hanspub.17107-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Uno, K., Niume, K., Iwata, Y., Toda, F. and Iwakura, Y. (1977) Synthesis of Polybenzimidazoles with Sulfonic Acid Groups. Journal of Polymer Science—Polymer Chemistry Edition, 15, 1309-1318.  
&lt;br&gt;http://dx.doi.org/10.1002/pol.1977.170150602</mixed-citation></ref><ref id="hanspub.17107-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">赵晶, 盛丽, 徐宏杰, 房建华, 印杰. 新型磺化聚苯并咪唑的合成及性能[J]. 高等学校化学学报, 2012, 33(3): 645-648.</mixed-citation></ref><ref id="hanspub.17107-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Nunami, K., Yamada, M., Fukui, T. and Matsumoto, K. (1994) A Novel Synthesis of Methyl 1,5-disubstitutedimida- zole-4-carboxylates Using 3-bromo-2-isocyanoacrylates. The Journal of Organic Chemistry, 59, 7635-7642.  
&lt;br&gt;http://dx.doi.org/10.1021/jo00104a018</mixed-citation></ref><ref id="hanspub.17107-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Pawar, V.G., De Borggraeve W.M., Robeyns, K., Meervelt, L.V., Compernollea, F. and Hoornaerta, G. (2006) Synthesis of 1,5-disubstituted 4-haloimidazoles from α-Aminonitriles. Tetrahedron Letters, 47, 5451-5453.  
&lt;br&gt;http://dx.doi.org/10.1016/j.tetlet.2006.05.181</mixed-citation></ref><ref id="hanspub.17107-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Bleicher, K.H., Gerber, F., Wüthrich, Y., Alanine, A. and Caprettab, A. (2002) Parallel Synthesis of Substituted Imidazoles from 1,2-aminoalcohols. Tetrahedron Letters, 43, 7687-7690.  
&lt;br&gt;http://dx.doi.org/10.1016/S0040-4039(02)01839-7</mixed-citation></ref><ref id="hanspub.17107-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Lantos, I., Zhang, W.Y., Shui, S.Q. and Eggleston, D.S. (1993) Synthesis of Imidazoles via Hetero-Cope Rearran- gements. The Journal of Organic Chemistry, 58, 7092-7095. &lt;br&gt;http://dx.doi.org/10.1021/jo00077a033</mixed-citation></ref><ref id="hanspub.17107-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Zaman, S., Mitsuru, K. and Abell, A.D. (2005) Synthesis of Trisubs-tituted Imidazoles by Palladium-Catalyzed Cyclization of O-Pentafluorobenzoylamidoximes: Application to Amino Acid Mimetics with a C-Terminal Imidazole. Organic Letters, 7, 609-611. &lt;br&gt;http://dx.doi.org/10.1021/ol047628p</mixed-citation></ref><ref id="hanspub.17107-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Durán, R., Zubía, E., Ortega, M.J., Naranjo, S. and Salyá, J. (1999) Novel Alkaloids from the Red Ascidian Botryllus Leachi. Tetrahedron, 55, 13225-13232. &lt;br&gt;http://dx.doi.org/10.1016/S0040-4020(99)00803-0</mixed-citation></ref><ref id="hanspub.17107-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Sonia, M., Javier, S. and Jesus Angel, D. (2006) Phenolic Marine Natural Products as Aldose Reductase Inhibitors. Journal of Natural Products, 69, 1485-1487. &lt;br&gt;http://dx.doi.org/10.1021/np0503698</mixed-citation></ref><ref id="hanspub.17107-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Zuliani, V., Cocconcelli, G., Fantini, M., Ghiron, C. and Rivara, M. (2007) A Practical Synthesis of 2,4(5)- diarylimidazoles from Simple Building Blocks. The Journal of Organic Chemi-stry, 72, 4551-4553.</mixed-citation></ref><ref id="hanspub.17107-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Khalili, B., Tondro, T. and Hashemi, M.M. (2009) Novel One-Pot Synthesis of (4 or 5)-aryl-2-aryloyl-(1H)-imidazoles in Water and Tauto-Isomerization Study Using NMR. Tetrahedron, 65, 6882-6887.  
&lt;br&gt;http://dx.doi.org/10.1016/j.tet.2009.06.082</mixed-citation></ref><ref id="hanspub.17107-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Batanero, B., Escudero, J. and Barba, F. (1999) Cathodic Reduction of Phenacyl Azides. Organic Letters, 1, 1521-1522.  
&lt;br&gt;http://dx.doi.org/10.1021/ol990200j</mixed-citation></ref><ref id="hanspub.17107-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Chen, J., Chen, W., Yu, Y.P. and Zhang, G.L. (2013) One-Pot Synthesis of Disubstitutedimidazole Derivatives from α-Azido Ketones Catalyzed by Potassium Ethylxanthate. Tetrahedron Letters, 54, 1572-1575.  
&lt;br&gt;http://dx.doi.org/10.1016/j.tetlet.2013.01.042</mixed-citation></ref><ref id="hanspub.17107-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Srinivasan, M., Perumal, S. and Selvaraj, S. (2006) A Facile Stereoselective Synthesis of (Z)-1,3-diaryl-2-(N- methylanilin-o)-2-propen-1-ones. ARKIVOC, 2006, 21-27.</mixed-citation></ref></ref-list></back></article>